Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

QTRX

Quanterix Corp

Jan 24 • 04:00PM ET

9.57

Dollar change -0.64
Percentage change -6.27	%

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA TWST GH EXAS TMO ABT DHR BIO QGEN

| Held by: VTI IWM VXF IWN IBB VTWO SCHA VHT FESM DFAT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.94	Insider Own	14.43%	Shs Outstand	38.48M	Perf Week	8.50%
Market Cap	368.68M	Forward P/E	-	EPS next Y	-0.98	Insider Trans	1.20%	Shs Float	32.97M	Perf Month	-8.86%
Income	-35.72M	PEG	-	EPS next Q	-0.25	Inst Own	87.28%	Short Float	6.33%	Perf Quarter	-23.56%
Sales	133.81M	P/S	2.76	EPS this Y	-10.05%	Inst Trans	3.06%	Short Ratio	3.61	Perf Half Y	-37.57%
Book/sh	8.81	P/B	1.09	EPS next Y	-3.83%	ROA	-8.50%	Short Interest	2.09M	Perf Year	-59.47%
Cash/sh	7.62	P/C	1.26	EPS next 5Y	4.80%	ROE	-10.32%	52W Range	8.21 - 29.70	Perf YTD	-9.97%
Dividend Est.	-	P/FCF	-	EPS past 5Y	12.06%	ROI	-9.58%	52W High	-67.78%	Beta	1.33
Dividend TTM	-	Quick Ratio	9.16	Sales past 5Y	22.91%	Gross Margin	59.28%	52W Low	16.57%	ATR (14)	0.86
Dividend Ex-Date	-	Current Ratio	10.07	EPS Y/Y TTM	9.35%	Oper. Margin	-37.44%	RSI (14)	42.97	Volatility	7.55% 8.30%
Employees	-	Debt/Eq	0.11	Sales Y/Y TTM	14.72%	Profit Margin	-26.69%	Recom	1.40	Target Price	18.60
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	-5.44%	Payout	-	Rel Volume	1.29	Prev Close	10.21
Sales Surprise	4.58%	EPS Surprise	13.79%	Sales Q/Q	14.29%	Earnings	Nov 12 AMC	Avg Volume	577.55K	Price	9.57
SMA20	-6.79%	SMA50	-14.49%	SMA200	-29.25%	Trades		Volume	743,060	Change	-6.27%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-01-24	Initiated	Scotiabank	Sector Outperform	$30
Sep-25-23	Upgrade	Canaccord Genuity	Hold → Buy	$25 → $32
Aug-08-23	Upgrade	SVB Securities	Market Perform → Outperform	$30
May-23-23	Upgrade	Goldman	Neutral → Buy	$13 → $27
Aug-15-22	Downgrade	Canaccord Genuity	Buy → Hold	$40 → $12
Aug-09-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$35 → $15
Aug-09-22	Downgrade	Cowen	Outperform → Market Perform	$38 → $18
Mar-02-22	Upgrade	Goldman	Sell → Neutral	$40
Oct-15-21	Resumed	Cowen	Outperform
Jun-04-21	Initiated	Goldman	Sell	$53

Jan-14-25 07:00AM	Quanterix Provides Update on Financial Performance (Business Wire) -5.93%
Jan-10-25 07:00AM	Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers (Business Wire) -19.69%
Jan-06-25 09:30AM	David R. Walt Receives National Medal of Technology and Innovation (Business Wire)
Jan-02-25 04:26PM	Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +12.27%
Dec-27-24 04:33AM	Down More Than 60%: Analysts Expect These 2 Beaten-Down Stocks to Rebound in 2025 (TipRanks)
06:59AM	Loading…
Dec-17-24 06:59AM	Quanterix Expands Capabilities with Strategic Acquisition of EMISSION (Business Wire)
Nov-22-24 05:00PM	Quanterix Announces Receipt of Expected Notice from Nasdaq (Business Wire) +5.70%
07:54AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (GlobeNewswire)
Nov-21-24 07:00AM	Wolf Haldenstein Adler Freeman and Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws (PR Newswire) +6.35%
Nov-13-24 02:18AM	Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ... (GuruFocus.com) -18.26%
Nov-12-24 04:01PM	Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024 (Business Wire)
Nov-11-24 07:14AM	Quanterix Corp (QTRX) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-05-24 04:00PM	Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire) +5.99%
Oct-28-24 04:30PM	New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information (Business Wire) +5.02%
Oct-09-24 05:55PM	Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ... (GuruFocus.com)
04:00PM	Loading…
Oct-02-24 04:00PM	Quanterix Welcomes Ivana Magovevi-Liebisch, Ph.D., J.D. to Board of Directors (Business Wire)
04:00PM	Quanterix Welcomes Ivana Magovcevic-Liebisch, Ph.D., J.D. to Board of Directors (Business Wire)
Sep-30-24 04:00PM	Quanterix Announces Commercialization of p-Tau 217 Test Kit (Business Wire)
Aug-29-24 04:00PM	Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-19-24 04:32PM	Jeffrey Elliott Appointed to Quanterixs Board of Directors (Business Wire) +7.66%
Aug-15-24 07:18PM	Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX) (GuruFocus.com) +9.25%
Aug-08-24 05:10PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -14.82%
04:00PM	Quanterix Releases Financial Results for the Second Quarter of 2024 (Business Wire)
Aug-06-24 04:00PM	Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference (Business Wire) -5.26%
Jul-31-24 04:00PM	Quanterix To Report Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 10:00AM	Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for (Zacks) -6.62%
08:00AM	Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimers Disease Detection that is More Effective than Standalone Plasma p-Tau 217 (Business Wire)
Jun-17-24 04:00PM	Quanterix to Participate at the Scotiabank Healthcare 1x1 Day (Business Wire) +5.48%
Jun-05-24 04:00PM	Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference (Business Wire)
May-22-24 04:00PM	Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 (Business Wire)
09:55AM	Loading…
May-15-24 09:55AM	Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade (Zacks) +6.30%
May-09-24 04:45PM	Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-07-24 09:00PM	QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Financial Results for the First Quarter of 2024 (Business Wire)
Apr-29-24 04:00PM	Quanterix To Report First Quarter 2024 Financial Results (Business Wire)
11:13AM	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating (MT Newswires)
Mar-21-24 05:30PM	Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure (Business Wire)
Mar-06-24 09:50AM	Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag (Zacks)
Mar-04-24 09:00AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimers Disease (Business Wire)
Mar-03-24 08:16AM	Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:26AM	Q4 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents) +12.69%
Feb-29-24 05:10PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:00PM	Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 (Business Wire)
Feb-27-24 10:03AM	Quanterix (QTRX) Expands in Alzheimer's Testing With Alliances (Zacks)
06:34AM	Quanterix Corp (QTRX) Aligns Earnings Release with Annual Report Filing, Reaffirms 2023 Guidance (GuruFocus.com)
Feb-26-24 09:00AM	Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimers Disease (Business Wire)
Feb-23-24 04:30PM	Quanterix to Present at Cowens 44th Annual Health Care Conference (Business Wire)
Feb-16-24 04:00PM	Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call (Business Wire)
Dec-12-23 04:00PM	Quanterix to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +8.77%
Dec-04-23 12:00PM	Here's Why Quanterix Corporation (QTRX) is a Great Momentum Stock to Buy (Zacks)
Nov-29-23 09:55AM	Does Quanterix Corporation (QTRX) Have the Potential to Rally 33.74% as Wall Street Analysts Expect? (Zacks)
Nov-13-23 04:00PM	Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) +9.47%
09:55AM	Wall Street Analysts See a 54.88% Upside in Quanterix Corporation (QTRX): Can the Stock Really Move This High? (Zacks)
07:00AM	Sotera Health Appoints Karen Flynn to Board of Directors (GlobeNewswire)
Nov-08-23 12:22PM	Quanterix Corporation (NASDAQ:QTRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-06-23 05:40PM	Quanterix Corp (QTRX) Raises Full-Year Revenue Expectations Following Q3 2023 Results (GuruFocus.com)
05:30PM	7 Stocks to Buy if You Anticipate a Hot November (InvestorPlace)
04:50PM	Quanterix Releases Operating Results for Third Quarter 202 (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate National Vision (EYE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-30-23 04:00PM	Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) +5.59%
Oct-24-23 04:30PM	Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimers Disease (Business Wire) +10.36%
Oct-23-23 08:30PM	Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection (Business Wire)
Oct-03-23 12:36PM	Quanterix (QTRX): A Closer Look at Its Modestly Undervalued Status (GuruFocus.com)
Sep-29-23 08:32AM	Zimmer Biomet (ZBH) Gains From ROSA Sales Growth Amid FX Woes (Zacks)
Sep-28-23 05:00PM	Quanterix CEO to Speak at Goldman Sachs Alzheimers Disease Day (Business Wire)
10:37AM	Abbott (ABT) Rides on Nutrition Recovery Amid Low Testing Sales (Zacks)
09:45AM	Quanterix Corporation (QTRX) Moves 7.2% Higher: Will This Strength Last? (Zacks)
Sep-27-23 11:40AM	Quanterix Corp (QTRX): An In-Depth Look at Its Undervalued Status (GuruFocus.com) +7.16%
07:51AM	Here's Why Investors Should Retain STERIS (STE) Stock for Now (Zacks)
07:47AM	Here's Why You Should Buy Align Technology (ALGN) Stock Now (Zacks)
Sep-21-23 09:42AM	Here's Why Investors Should Buy Alcon (ALC) Stock Right Now (Zacks)
Sep-15-23 08:21AM	Here's Why You Should Retain Insulet (PODD) Stock for Now (Zacks)
Sep-13-23 08:16AM	Here's Why You Should Invest in Edward Lifesciences (EW) Now (Zacks)
Sep-06-23 10:04AM	Here's Why You Should Retain Omnicell (OMCL) Stock Now (Zacks)
09:48AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Sep-05-23 08:00AM	Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-31-23 08:37AM	Here's Why You Should Retain Integra (IART) Stock for Now (Zacks)
Aug-30-23 09:32AM	Here's Why You Should Retain Zimmer Biomet (ZBH) for Now (Zacks)
Aug-25-23 10:26AM	Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth (Zacks)
09:34AM	BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model (Zacks)
09:14AM	Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch (Zacks)
09:04AM	Here's Why You Should Retain Tandem Diabetes (TNDM) Now (Zacks)
Aug-21-23 04:30PM	William P. Donnelly Appointed to Quanterixs Board of Directors (Business Wire)
Aug-09-23 08:30AM	Quanterix Appoints Vandana Sriram as Chief Financial Officer (Business Wire)
Aug-07-23 07:40PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.03% +16.89%
05:13PM	Quanterix Releases Operating Results for Second Quarter 2023 (Business Wire)
Aug-03-23 08:00AM	Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference (Business Wire) -5.68%
Jul-31-23 08:00AM	Quanterixs Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients (Business Wire) +6.43%
Jul-26-23 11:29AM	Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation (Simply Wall St.)
Jul-20-23 08:00AM	Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023 (Business Wire)
Jul-10-23 11:08AM	Quanterix (QTRX) Advances in Alzheimer's Diagnosis With LucentAD (Zacks)
02:01AM	Quanterix Corporation (QTRX) Surges 13.6%: Is This an Indication of Further Gains? (Zacks)
Jul-06-23 05:37PM	Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimers Disease in Patients (Business Wire) +13.57%
Jun-29-23 09:35AM	Bullish Quanterix Insiders Loaded Up On US$5.6m Of Stock (Simply Wall St.)
Jun-07-23 04:00PM	Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference (Business Wire)
May-24-23 02:27AM	4 big analyst picks: Sherwin-Williams a buy at Jefferies on firming housing market (Investing.com)
May-16-23 11:01AM	Shareholders in Quanterix (NASDAQ:QTRX) are in the red if they invested three years ago (Simply Wall St.)
May-10-23 06:52AM	Q1 2023 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WALT DAVID R	Director	Aug 20 '24	Buy	13.29	47,000	624,630	1,487,342	Sep 17 04:35 PM
Toloue Masoud	President & CEO	Aug 13 '24	Buy	10.90	19,000	207,100	354,119	Aug 15 04:03 PM
OLSON LAURIE J	Director	May 14 '24	Sale	16.98	1,500	25,470	13,738	May 14 04:02 PM
OLSON LAURIE J	Director	Apr 01 '24	Option Exercise	12.86	1,000	12,860	16,238	Apr 02 04:00 PM
OLSON LAURIE J	Director	Apr 01 '24	Sale	23.50	1,000	23,500	15,238	Apr 02 04:00 PM
OLSON LAURIE J	Director	Feb 14 '24	Sale	24.35	1,500	36,525	15,238	Feb 15 05:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QTRX

Quanterix Corp

Upgrade your FINVIZ experience